DEA eases production limits for some narcotics amid shortage during pandemic

The Drug Enforcement Administration has increased production limits for some controlled substances that have seen demand spike due to the COVID-19 pandemic, the Regina Leader-Post reported.

The agency said April 7 it will increase limits on certain controlled substances by 15 percent, including fentanyl, morphine and hydromorphone, as well as some cough or cold medicine ingredients, including codeine, ephedrine and pseudoephedrine.